Chemicals & Advanced Materials Global On demand · 24-48h

Global Polyurethane Indwelling Needle Market Strategic Research Report

Global Polyurethane Indwelling Needle Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Polyurethane Indwelling Needle Market
$1.57B2025
6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single-use Polyurethane Cannula, Over-the-Needle Polyurethane Cannula, Through-the-Needle Polyurethane Cannula

By Application: Peripheral IV Cannula, Central Venous Catheter

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Becton Dickinson (BD), B. Braun, Terumo, Nipro, Teleflex, Smiths Medical, Vygon, ICU Medical, Ande Medical, Weigao Group, Shanghai Kindly Enterprise Development Group, Baihe Medical, Zhejiang Fert Medical Device, Shanghai Zhengbang Medical, Medikit

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 107 pages
Market size 2025
$1.57B
Billion USD
Forecast CAGR
6%
2025-2032
Forecast 2032
$2.4B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Polyurethane Indwelling Needle market size is predicted to grow from US$ 1,568 million in 2025 to US$ 2,345 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

Polyurethane Indwelling Needle refers to a medical device made primarily of polyurethane material, designed for intravenous access and long-term venous infusion. It consists of a flexible catheter and a sharp introducer needle, allowing safe puncture into peripheral or central veins. The polyurethane material provides high biocompatibility, superior flexibility, and reduced risk of phlebitis or thrombosis compared to conventional PVC devices. This device is widely used for the administration of fluids, medications, blood transfusions, and parenteral nutrition, and it ensures patient comfort during prolonged infusion procedures. Advanced designs may include safety mechanisms to prevent needle-stick injuries and closed systems to reduce contamination risk.

Polyurethane indwelling needles are used in hospitals, outpatient clinics, home care, nursing facilities, and research laboratories. Depending on clinical requirements, they are available in different gauges, lengths, and safety features to accommodate peripheral intravenous (PIV) and central venous catheter (CVC) applications. The device supports continuous infusion, blood sampling, and automated infusion systems. With growing awareness of patient safety, infection control, and improved patient comfort, polyurethane indwelling needles are becoming the preferred choice over traditional materials for high-end clinical applications.

In 2025, global Polyurethane Indwelling Needle production reached approximately 594 million units, with an average market price of around US$2.7 per unit.

The global Polyurethane Indwelling Needle market has experienced strong growth due to increasing adoption of high-end intravenous devices, growing awareness of patient safety, and rising demand for long-term infusion therapies in hospitals, outpatient clinics, and home care settings. Polyurethane needles are preferred over traditional PVC products for their superior biocompatibility, flexibility, and patient comfort, as well as their reduced risk of phlebitis and thrombosis. Safety features, including needle-stick prevention mechanisms and closed systems, further drive adoption in clinical environments.

Several factors contribute to market expansion. The rapid growth of healthcare infrastructure, aging populations, increasing prevalence of chronic diseases, and higher demand for chemotherapy, parenteral nutrition, and intravenous drug administration boost the need for reliable and safe venous access devices. Hospitals and clinics are increasingly replacing conventional PVC catheters with polyurethane variants, particularly in high-end wards, intensive care units (ICU), and surgical settings. Technological improvements in catheter design, safety systems, and infection prevention also promote wider clinical adoption.

Regionally, North America and Europe represent mature markets with high adoption rates of polyurethane indwelling needles in hospitals and outpatient care. Asia-Pacific is the fastest-growing market, driven by expanding healthcare infrastructure, increasing hospital bed capacities, and growing awareness of infection control and patient comfort. Emerging markets in Latin America, the Middle East, and Africa are gradually increasing adoption as healthcare access and quality improve.

Despite strong growth, challenges include higher unit costs compared to PVC devices, regulatory compliance requirements, and the need for skilled healthcare personnel to ensure proper insertion and maintenance. Suppliers focus on product innovation, cost optimization, and expanding distribution networks to increase market penetration. Future trends point toward enhanced safety features, eco-friendly and recyclable materials, and integration with smart infusion systems to optimize patient care and operational efficiency.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Polyurethane Indwelling Needle market?

What factors are driving Polyurethane Indwelling Needle market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Polyurethane Indwelling Needle market opportunities vary by end market size?

How does Polyurethane Indwelling Needle break out by Type, by Application?

This report presents a comprehensive overview of the global Polyurethane Indwelling Needle market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single-use Polyurethane Cannula
  • Over-the-Needle Polyurethane Cannula
  • Through-the-Needle Polyurethane Cannula

Segment by Application

  • Hospital
  • Clinical
  • Home Care
  • Others

Segment by Application

  • Peripheral IV Cannula
  • Central Venous Catheter

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Polyurethane Indwelling Needle market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Peripheral IV Cannula, Central Venous Catheter evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Polyurethane Indwelling Needle Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.57B
2025
Forecast
$2.4B
2032
CAGR
6%
2025–2032
リージョン
5
global
Key companies
Becton Dickinson (BD)B. BraunTerumoNiproTeleflexSmiths MedicalVygonICU Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single-use Polyurethane CannulaOver-the-Needle Polyurethane CannulaThrough-the-Needle Polyurethane Cannula
By Application
Peripheral IV CannulaCentral Venous Catheter

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single-use Polyurethane Cannula
  • 3.1.3 Over-the-Needle Polyurethane Cannula
  • 3.1.4 Through-the-Needle Polyurethane Cannula
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Peripheral IV Cannula
  • 4.1.3 Central Venous Catheter
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Becton Dickinson (BD)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 B. Braun
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Terumo
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Nipro
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Teleflex
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Smiths Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Vygon
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 ICU Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Ande Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Weigao Group
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shanghai Kindly Enterprise Development Group
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Baihe Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Zhejiang Fert Medical Device
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Shanghai Zhengbang Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Medikit
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Polyurethane Indwelling Needle market size?
The global Polyurethane Indwelling Needle market is estimated at US$ 1.57 billion in 2025 (base year) and is projected to reach US$ 2.35 billion by 2032.
What growth rate is expected for the Polyurethane Indwelling Needle market through 2032?
The market is expected to grow at a CAGR of 6.0% from 2026 to 2032, expanding from US$ 1.57 billion in 2025 to US$ 2.35 billion in 2032, roughly 1.5 times its base-year value.
How is Polyurethane Indwelling Needle defined?
Polyurethane Indwelling Needle refers to a medical device made primarily of polyurethane material, designed for intravenous access and long-term venous infusion. It consists of a flexible catheter and a sharp introducer needle, allowing safe puncture into peripheral or central veins. The polyurethane material provides high biocompatibility, superior flexibility, and reduced risk of phlebitis or thrombosis compared to conventional PVC devices.
How is the Polyurethane Indwelling Needle market segmented by type?
By type, the market is segmented into Single-use Polyurethane Cannula, Over-the-Needle Polyurethane Cannula and Through-the-Needle Polyurethane Cannula.
What are the key applications of Polyurethane Indwelling Needle?
Key applications covered include Peripheral IV Cannula and Central Venous Catheter.
Which companies are profiled in the Polyurethane Indwelling Needle market report?
Key players profiled include Becton Dickinson (BD), B. Braun, Terumo, Nipro, Teleflex, Smiths Medical, Vygon and ICU Medical, among 15 companies covered in total.
What geographies does the Polyurethane Indwelling Needle market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Polyurethane Indwelling Needle?
Asia-Pacific is the fastest-growing market, driven by expanding healthcare infrastructure, increasing hospital bed capacities, and growing awareness of infection control and patient comfort.
What are the main risks and barriers in the Polyurethane Indwelling Needle market?
Despite strong growth, challenges include higher unit costs compared to PVC devices, regulatory compliance requirements, and the need for skilled healthcare personnel to ensure proper insertion and maintenance.
Who should buy the Polyurethane Indwelling Needle market report?
The report is intended for manufacturers and solution providers, distributors and end users in Peripheral IV Cannula and Central Venous Catheter, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Polyurethane Indwelling Needle market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.